Recent research indicates that smoking cannabis carries fewer risks for lung health compared to smoking tobacco, with no direct association found between cannabis use and the development of emphysema. This conclusion stems from a study published in the journal Current Problems in Diagnostic Radiology, where researchers from Harvard Medical School analyzed chest CT scans of 285 participants.
Among the subjects, 89 identified as non-smokers, 97 were tobacco smokers, and 99 were cannabis smokers. The findings revealed that participants who smoked tobacco exhibited significantly greater damage to their cardiovascular and pulmonary systems than those who solely used cannabis. Specifically, tobacco smokers demonstrated a higher likelihood of experiencing moderate to severe coronary artery calcification and emphysema.
The study’s authors stated, “The findings of our study collectively highlight the distinct patterns of pulmonary and cardiovascular manifestations associated with smoking and marijuana use. In general, marijuana users do not appear to develop emphysema or pulmonary hyperinflation.” This aligns with previous studies suggesting that cannabis smoke is not as carcinogenic as tobacco smoke and is not linked to increased risks of chronic obstructive pulmonary disease (COPD), lung cancer, or other tobacco-related health issues.
Additionally, the use of vaporization technology for cannabis—heating the herb below combustion temperatures—has been shown to lower exposure to harmful gases and is regarded as a safe and effective method for cannabis consumption in clinical trials.
Paul Armentano, Deputy Director of NORML (National Organization for the Reform of Marijuana Laws), commented on the implications of the study. He pointed out that public perception aligns with the findings, as most Americans recognize that tobacco smoking presents greater health risks than cannabis use. Despite this, cannabis continues to be classified as a Schedule I controlled substance under federal law, while tobacco products—linked to hundreds of thousands of preventable deaths annually—remain unregulated at the federal level.
Armentano emphasized, “It makes no sense from either a public health standpoint or a political standpoint to continue treating marijuana as if it is more dangerous than tobacco. The science is clear and consistent; it is not.”
The abstract of the study titled “Quantitative and qualitative imaging in marijuana users and smokers” is available through ScienceDirect, and further information can be found in NORML’s Fact Sheet on ‘Cannabis Exposure and Lung Health.’ This research contributes to the ongoing dialogue about the relative safety of cannabis compared to traditional tobacco products.
